• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 16S rRNA 的微生物组分析有助于对小儿囊性纤维化患者气道样本的常规培养分析。

16S rRNA-Based Microbiota Profiling Assists Conventional Culture Analysis of Airway Samples from Pediatric Cystic Fibrosis Patients.

机构信息

Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.

Spaarne Gasthuis Academy, Spaarne Gasthuis, Hoofddorp, The Netherlands.

出版信息

Microbiol Spectr. 2023 Jun 15;11(3):e0405722. doi: 10.1128/spectrum.04057-22. Epub 2023 May 18.

DOI:10.1128/spectrum.04057-22
PMID:37199622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10269535/
Abstract

16S-based sequencing provides broader information on the respiratory microbial community than conventional culturing. However, it (often) lacks species- and strain-level information. To overcome this issue, we used 16S rRNA-based sequencing results from 246 nasopharyngeal samples obtained from 20 infants with cystic fibrosis (CF) and 43 healthy infants, which were all 0 to 6 months old, and compared them to both standard (blind) diagnostic culturing and a 16S-sequencing-informed "targeted" reculturing approach. Using routine culturing, we almost uniquely detected Moraxella catarrhalis, Staphylococcus aureus, and Haemophilus influenzae (42%, 38%, and 33% of samples, respectively). Using the targeted reculturing approach, we were able to reculture 47% of the top-5 operational taxonomical units (OTUs) in the sequencing profiles. In total, we identified 60 species from 30 genera with a median of 3 species per sample (range, 1 to 8). We also identified up to 10 species per identified genus. The success of reculturing the top-5 genera present from the sequencing profile depended on the genus. In the case of being in the top 5, we recultured them in 79% of samples, whereas for Staphylococcus, this value was only 25%. The success of reculturing was also correlated with the relative abundance of those genera in the corresponding sequencing profile. In conclusion, revisiting samples using 16S-based sequencing profiles to guide a targeted culturing approach led to the detection of more potential pathogens per sample than conventional culturing and may therefore be useful in the identification and, consequently, treatment of bacteria considered relevant for the deterioration or exacerbation of disease in patients like those with CF. Early and effective treatment of pulmonary infections in cystic fibrosis is vital to prevent chronic lung damage. Although microbial diagnostics and treatment decisions are still based on conventional culture methods, research is gradually focusing more on microbiome and metagenomic-based approaches. This study compared the results of both methods and proposed a way to combine the best of both worlds. Many species can relatively easily be recultured based on the 16S-based sequencing profile, and it provides more in-depth information about the microbial composition of a sample than that obtained through routine (blind) diagnostic culturing. Still, well-known pathogens can be missed by both routine diagnostic culture methods as well as by targeted reculture methods, sometimes even when they are highly abundant, which may be a consequence of either sample storage conditions or antibiotic treatment at the time of sampling.

摘要

16S 测序比传统培养提供了更广泛的呼吸微生物群落信息。然而,它(通常)缺乏物种和菌株水平的信息。为了克服这个问题,我们使用了 246 份来自 20 名囊性纤维化(CF)婴儿和 43 名健康婴儿的鼻咽样本的 16S rRNA 测序结果,这些婴儿均为 0 至 6 个月大,并将其与标准(盲法)诊断培养和基于 16S 测序的“靶向”重培养方法进行了比较。使用常规培养,我们几乎可以单独检测到卡他莫拉菌、金黄色葡萄球菌和流感嗜血杆菌(分别为 42%、38%和 33%的样本)。使用靶向重培养方法,我们能够重培养测序图谱中前 5 位操作分类单元(OTUs)的 47%。总共从 30 个属中鉴定出 60 个种,每个样本的中位数为 3 个种(范围为 1 到 8)。我们还在每个鉴定属中鉴定出多达 10 个种。根据属的不同,从测序图谱中重培养前 5 位存在的属的成功率也不同。在属于前 5 位的情况下,我们在 79%的样本中重培养了它们,而对于金黄色葡萄球菌,这一比例仅为 25%。重培养的成功率也与相应测序图谱中这些属的相对丰度相关。总之,使用基于 16S 的测序图谱重新检查样本以指导靶向培养方法可以比传统培养检测到更多的潜在病原体,因此可能有助于识别和,因此,对于囊性纤维化等患者疾病恶化或恶化相关的细菌进行治疗。早期和有效的囊性纤维化肺部感染治疗对于预防慢性肺损伤至关重要。尽管微生物诊断和治疗决策仍然基于传统的培养方法,但研究正逐渐更多地关注微生物组和宏基因组方法。本研究比较了这两种方法的结果,并提出了一种结合两者优势的方法。许多物种可以根据 16S 测序图谱相对容易地进行再培养,并且它提供了比常规(盲法)诊断培养更深入的样本微生物组成信息。尽管如此,常规诊断培养方法和靶向重培养方法都可能会错过一些知名病原体,有时即使它们高度丰富,这可能是样本储存条件或采样时抗生素治疗的结果。

相似文献

1
16S rRNA-Based Microbiota Profiling Assists Conventional Culture Analysis of Airway Samples from Pediatric Cystic Fibrosis Patients.基于 16S rRNA 的微生物组分析有助于对小儿囊性纤维化患者气道样本的常规培养分析。
Microbiol Spectr. 2023 Jun 15;11(3):e0405722. doi: 10.1128/spectrum.04057-22. Epub 2023 May 18.
2
Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.婴儿期囊性纤维化患者鼻咽微生物组的发育。
Am J Respir Crit Care Med. 2016 Mar 1;193(5):504-15. doi: 10.1164/rccm.201509-1759OC.
3
Concordance between upper and lower airway microbiota in infants with cystic fibrosis.婴儿囊性纤维化上下呼吸道微生物群落的一致性。
Eur Respir J. 2017 Mar 29;49(3). doi: 10.1183/13993003.02235-2016. Print 2017 Mar.
4
Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.成人囊性纤维化患者气道微生物群中的真菌和细菌多样性:传统方法与超深度测序的一致性及其在临床实验室中的实际应用。
Mycopathologia. 2018 Feb;183(1):171-183. doi: 10.1007/s11046-017-0185-x. Epub 2017 Aug 1.
5
The metabolic footprint of the airway bacterial community in cystic fibrosis.囊性纤维化气道细菌群落的代谢足迹。
Microbiome. 2017 Jun 30;5(1):67. doi: 10.1186/s40168-017-0289-z.
6
Culture-Independent Analysis of Pediatric Bronchoalveolar Lavage Specimens.儿童支气管肺泡灌洗液的无培养分析。
Ann Am Thorac Soc. 2018 Sep;15(9):1047-1056. doi: 10.1513/AnnalsATS.201802-146OC.
7
Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.不同的下一代测序平台在囊性纤维化痰液中产生不同的微生物谱和多样性。
J Microbiol Methods. 2016 Nov;130:95-99. doi: 10.1016/j.mimet.2016.09.002. Epub 2016 Sep 5.
8
Culture enriched molecular profiling of the cystic fibrosis airway microbiome.文化富集的囊性纤维化气道微生物组分子特征分析。
PLoS One. 2011;6(7):e22702. doi: 10.1371/journal.pone.0022702. Epub 2011 Jul 28.
9
Divergence of bacterial communities in the lower airways of CF patients in early childhood.婴幼儿 CF 患者下呼吸道细菌群落的差异。
PLoS One. 2021 Oct 6;16(10):e0257838. doi: 10.1371/journal.pone.0257838. eCollection 2021.
10
Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.成人囊性纤维化患者鼻窦微生物组随时间推移的多样性低且不稳定。
Microbiol Spectr. 2022 Oct 26;10(5):e0125122. doi: 10.1128/spectrum.01251-22. Epub 2022 Sep 12.

引用本文的文献

1
Corynebacterium pseudodiphtheriticum as etiologic agent of human infections worldwide: a review of case reports within the last 40 years (1983-2023).全球范围内人类感染的假白喉棒状杆菌病原体:过去40年(1983 - 2023年)病例报告综述
Braz J Microbiol. 2025 Jul 16. doi: 10.1007/s42770-025-01739-1.
2
Airway Mycobiota-Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study.囊性纤维化患者肺部加重期气道真菌群-微生物群:一项培养与靶向测序研究
Mycoses. 2025 Jan;68(1):e70024. doi: 10.1111/myc.70024.

本文引用的文献

1
High proportions of bacteria are culturable across major biomes.在各大生物群落中,可培养的细菌比例很高。
ISME J. 2019 Aug;13(8):2125-2128. doi: 10.1038/s41396-019-0410-3. Epub 2019 Apr 5.
2
Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory.了解并克服下一代测序(NGS)方法在常规临床微生物学诊断实验室应用中的陷阱和偏见。
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1059-1070. doi: 10.1007/s10096-019-03520-3. Epub 2019 Mar 5.
3
Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis.
囊性纤维化患儿下呼吸道感染患病率的变化。
Am J Respir Crit Care Med. 2019 Sep 1;200(5):590-599. doi: 10.1164/rccm.201810-1919OC.
4
Respiratory Microbiome Profiling for Etiologic Diagnosis of Pneumonia in Mechanically Ventilated Patients.机械通气患者肺炎病因诊断的呼吸道微生物群分析
Front Microbiol. 2018 Jul 10;9:1413. doi: 10.3389/fmicb.2018.01413. eCollection 2018.
5
Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.成人囊性纤维化患者气道微生物群中的真菌和细菌多样性:传统方法与超深度测序的一致性及其在临床实验室中的实际应用。
Mycopathologia. 2018 Feb;183(1):171-183. doi: 10.1007/s11046-017-0185-x. Epub 2017 Aug 1.
6
Development of the respiratory tract microbiota in cystic fibrosis.囊性纤维化患者呼吸道微生物群的发育
Curr Opin Pulm Med. 2016 Nov;22(6):623-628. doi: 10.1097/MCP.0000000000000316.
7
The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study.婴儿期囊性纤维化患儿鼻腔微生物群的前瞻性队列研究。
Lancet Respir Med. 2016 Aug;4(8):627-635. doi: 10.1016/S2213-2600(16)30081-9. Epub 2016 May 11.
8
MALDI-TOF mass spectrometry for differentiation between Streptococcus pneumoniae and Streptococcus pseudopneumoniae.用于区分肺炎链球菌和伪肺炎链球菌的基质辅助激光解吸电离飞行时间质谱分析
Diagn Microbiol Infect Dis. 2016 May;85(1):9-11. doi: 10.1016/j.diagmicrobio.2016.01.012. Epub 2016 Jan 22.
9
Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens.基于培养法和非培养法的囊性纤维化呼吸道标本细菌学分析
J Clin Microbiol. 2016 Mar;54(3):613-9. doi: 10.1128/JCM.02299-15. Epub 2015 Dec 23.
10
Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.婴儿期囊性纤维化患者鼻咽微生物组的发育。
Am J Respir Crit Care Med. 2016 Mar 1;193(5):504-15. doi: 10.1164/rccm.201509-1759OC.